Tag Archives: GPCR

January, 2016

• 15 January

  Boehringer Ingelheim Inks $262 Million CNS Deal with Arena Pharmaceuticals

  

  INGELHEIM, Germany, and SAN DIEGO, Jan. 12, 2016 /PRNewswire/ — Boehringer Ingelheim and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that they have signed an exclusive agreement to conduct joint research to identify drug candidates targeting an undisclosed G protein-coupled receptor (GPCR), which belongs to the group of orphan CNS …

  Share

  • Facebook
  • Twitter
  • LinkedIn

December, 2015

• 2 December

  Pfizer Enters GPCR-Based Therapy Deal with Heptares

  

  TOKYO–(BUSINESS WIRE)–Sosei Group Corporation (“Sosei”) (TOKYO:4565) today announces that its wholly-owned subsidiary, Heptares Therapeutics has entered into a strategic drug discovery collaboration with Pfizer Inc. (NYSE: PFE) to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas. Heptares will …

  Share

  • Facebook
  • Twitter
  • LinkedIn